Talas, Zainarah C.
HRN: 22-13-26 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/25/2022
AMPICILLIN 250MG (VIAL)
10/25/2022
11/01/2022
IV
170mg
Q12
Psnb
Waiting Final Action
10/25/2022
GENTAMICIN 40MG/ML, 2ML (AMP)
10/25/2022
11/01/2022
IV
17mg
Q24
Psnb
Waiting Final Action